《风湿病学杂志》于1974年首次出版，是由西尔弗曼伯爵编辑的国际期刊。该杂志以风湿病学和相关领域的科学家发表的关于临床课题的同行评审研究文章为特色，得到了我们尊敬的编辑委员会和编辑委员会的支持。根据加拿大基础期刊的研究，风湿病学杂志被列为风湿病学的三大基础出版物之一。事实上，74%的风湿病学家认为《风湿病杂志》是一本必不可少的杂志，使其成为该专业的顶级杂志。《风湿病学杂志》每月出版及时的临床研究论文，包括印刷版和在线版。《风湿病学杂志》每年引文数千篇，覆盖全球3600多个订阅者和加拿大风湿病学协会所有活跃成员，包括风湿病学居民和受训者。《风湿病学杂志》的内容自40多年前建立以来，一直与风湿病学家密切相关，因为它强调持续性，同时接受创新。《风湿病学杂志》每年有来自50多个国家的1600多篇论文提交，每期包括原始临床研究文章、元分析、系统综述、社论、历史小插曲、病例报告和世界知名药物治疗专家的来信、患者报告的结果、发现治疗目标。在治疗类风湿关节炎、强直性脊柱炎、银屑病关节炎、骨关节炎等风湿性疾病和肌肉骨骼疾病方面。《风湿病杂志》以加拿大和国外著名风湿病学家在《风湿病补充杂志》上发表的全国和国际会议或专题讨论会论文为特色。这些及时补充通常突出了有关风湿性疾病机制的报告和新疗法的最新进展。
http://mc.manuscriptcentral.com/jrheum
First published in 1974, The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features peer-reviewed research articles on clinical subjects from scientists working in rheumatology and related fields, with the support of our esteemed Editorial Committee and Editorial Board.According to The Canadian Essential Journal Study, The Journal of Rheumatology is ranked among the top 3 essential publications for rheumatology. In fact, 74% of rheumatologists consider The Journal of Rheumatology an essential journal, making it the top journal in the specialty.The Journal of Rheumatology publishes timely clinical research papers every month, both in print and online. With thousands of citations per year, The Journal of Rheumatology’s influence and reach extends to over 3600 subscribers globally and to all active members of the Canadian Rheumatology Association, including rheumatology residents and trainees. Since it was established over 40 years ago, The Journal of Rheumatology’s content remains highly relevant to rheumatologists because of the emphasis on continuity while embracing innovation.With over 1600 submissions a year from over 50 countries, each issue of The Journal of Rheumatology includes original clinical research articles, metaanalyses, systematic reviews, editorials, historical vignettes, case reports, and letters by world-renowned experts studying drug therapy, patient-reported outcomes, discovery of therapeutic targets in the treatment of rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis, and other rheumatic and musculoskeletal diseases.The Journal of Rheumatology features proceedings of national and international conferences or symposia presented by renowned rheumatologists from Canada and abroad in The Journal of Rheumatology Supplements. These timely supplements typically highlight reports on the mechanisms of rheumatic diseases and updates on emerging therapies.
